rs2298526

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.52+20078T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 151,624 control chromosomes in the GnomAD database, including 16,769 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16769 hom., cov: 32)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.169

Publications

6 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.78 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.52+20078T>C intron_variant Intron 1 of 19 ENST00000316851.12 NP_851996.2 P13591-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.52+20078T>C intron_variant Intron 1 of 19 5 NM_181351.5 ENSP00000318472.8 P13591-2

Frequencies

GnomAD3 genomes
AF:
0.458
AC:
69423
AN:
151506
Hom.:
16739
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.420
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.507
Gnomad ASJ
AF:
0.414
Gnomad EAS
AF:
0.800
Gnomad SAS
AF:
0.586
Gnomad FIN
AF:
0.672
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.408
Gnomad OTH
AF:
0.439
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.458
AC:
69498
AN:
151624
Hom.:
16769
Cov.:
32
AF XY:
0.476
AC XY:
35287
AN XY:
74122
show subpopulations
African (AFR)
AF:
0.420
AC:
17397
AN:
41390
American (AMR)
AF:
0.507
AC:
7700
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
1430
AN:
3456
East Asian (EAS)
AF:
0.801
AC:
4113
AN:
5138
South Asian (SAS)
AF:
0.586
AC:
2822
AN:
4814
European-Finnish (FIN)
AF:
0.672
AC:
7096
AN:
10552
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.408
AC:
27624
AN:
67766
Other (OTH)
AF:
0.442
AC:
931
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1874
3748
5623
7497
9371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.447
Hom.:
2064
Bravo
AF:
0.442
Asia WGS
AF:
0.633
AC:
2200
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.92
DANN
Benign
0.47
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2298526; hg19: chr11-112852464; API